Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riociguat long-term extension in pulmonary arterial hypertension (CHEST-1 extension)
CTR20131731Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of riociguat in pulmonary arterial hypertension (PAH), sponsored by Bayer. Started Apr 2014; status: completed.
02
Drugs
riociguat
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on CTR20131731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131731.